Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

New research reveals these medications impact everything from heart health to restaurant menus.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity ...

Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

At the 44th Annual JP Morgan Healthcare conference 2026, Eli Lilly highlighted lepodisiran and muvalaplin as the key drugs in ...

Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Physicians used significantly lower amounts of two heart drugs in hospital settings following major price spikes on the medications, according to Cleveland Clinic research published Thursday in The ...

The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...

In a recent article in the journal Antioxidants, researchers in Germany investigated whether cardiovascular drugs such as alpha-blockers and beta-blockers can protect against the complications caused ...

The FDA states new diabetes drugs now need to show a lack of cardiovascular toxicity. Despite initial reservations, companies are cooperating, and some are even seeking the holy grail of ...